Intermittent claudication

British Medical Journal

Volumn 333, Issue 7576, 2006, Pages 1002-1005

  Cassar, Kevin ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ALPHA TOCOPHEROL; ANTITHROMBOCYTIC AGENT; BUFLOMEDIL; CILOSTAZOL; DG 041; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER X RECEPTOR; OMEGA 3 FATTY ACID; PENTOXIFYLLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E3; SCATTER FACTOR; VASCULOTROPIN;

ANKLE BRACHIAL INDEX; ARTERY BLOOD FLOW; ARTERY OCCLUSION; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BYPASS SURGERY; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; DIABETES CONTROL; DIARRHEA; DIFFERENTIAL DIAGNOSIS; ENDARTERECTOMY; EXCIMER LASER; EXERCISE; HEADACHE; HEART PALPITATION; HIGH RISK POPULATION; HUMAN; INTERMITTENT CLAUDICATION; LASER ANGIOPLASTY; LIPOPROTEIN METABOLISM; MEDICAL PRACTICE; MEDLINE; MORTALITY; MUSCLE CRAMP; MUSCLE ISCHEMIA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SMOKING CESSATION; SOCIOECONOMICS; SURGICAL TECHNIQUE; AMPUTATION; FORECASTING; KINESIOTHERAPY; LEG; RISK FACTOR; SURVIVAL; VASCULARIZATION;

AMPUTATION; EXERCISE THERAPY; FORECASTING; HUMANS; INTERMITTENT CLAUDICATION; LEG; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33750941064     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39001.562813.DE     Document Type: Review

References (23)

1. Garcia LA. Epidemiology and pathophysiology of peripheral arterial disease. J Endovasc Ther 2006; 13(suppl 2):I13-9.
2. Diehm C, Kareem S, Lawall H. Epidemiology of peripheral arterial disease. Vasa 2004;33:183-9.
3. Marquis P. Evaluation of the impact of peripheral obliterative arteriopathy on quality of life. Drugs 1998;56(suppl 3):25-35.
4. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication: a risk profile from the Framingham heart study. Circulation 1997;96:44-9.
5. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley diabetes study. Circulation 1995;91:1472-9.
6. Muluk SC, Muluk VS, Kelley ME, Whittle JC, Tierney JA, Webster MW, et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. Vasc Surg 2001;33:251-7.
7. Dormandy JA, Murray GD. The fate of the claudicant - a prospective study of 1969 claudicants. Eur J Vasc Surg 1991;5:131-3.
8. Newman AB, Siscovick DS, Manoglio TA, Polak J, Fride LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study. Circulation 1993;88:837-45.
9. Leng GC, Papacosta O, Whincup P, Wannamethee G, Walker M, Ebrahim S, et al. Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis 2000;152:167-74.
10. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004;(3):CD000146.
11. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database, Syst Rev 2004;(4):CD000031.
12. Scottish Intercollegiate Guidelines Network. Drug therapy for peripheral vascular disease: a national clinical guideline. Edinburgh: SIGN, 1998. (www.sign.ac.uk/pdf.sign27.pdf)
13. Cassar K, Bachoo P. Peripheral arterial disease. Clin Evid 2006;(15):164-76.
14. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol 1995;75:894-903.
15. Staessen JA, Fagard R, Thijs L, for the Systolic Hypertension in Europe Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64.
16. Vijan S, Hypertension in diabetes. Clin Evid 2005;(14):491-500.
17. Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80(suppl 2):S1-29.
18. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000;(2):CD000990.
19. Cassar K, Bachoo P, Brittenden J. The impact of peripheral percutaneous transluminal angioplasty on quality of life in intermittent claudication. Eur J Vasc Endovasc Surg 2003;26:130-6.
20. Fowkes FGR, Gillespie IN. Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database Syst Rev 1998;(2):CD000017.
21. Bachoo P, Thorpe P. Endovascular stents for intermittent claudication. Cochrane Database Syst Rev 2002;(4):CD003228.
22. Transatlantic Inter-Society Consensus (TASC) Working Group. Management of peripheral arterial occlusive disease: TASC document. J Vasc Surg 2000;31(suppl):S1-27.
23. Leng GC, Davis M, Baker D. Bypass surgery for chronic lower limb ischaemia. Cochrane Database Syst Rev 2000;(3):CD002000.